Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05688280
Title Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (INJECTABL-1)
Acronym INJECTABL-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Immunophotonics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | DEU | CHE


No variant requirements are available.